SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced today that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent...
Hence then, the article about abbisko therapeutics announces fda acceptance of the nda for pimicotinib for the treatment of tenosynovial giant cell tumor was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor )
Also on site :
- Police respond to incident at property in Dudley as residents 'spot armed police' in street
- Sinkhole on East Franklin Street Closes Lanes; Chapel Hill Urges for Detours
- Fire crews and Hazmat teams responded to fire involving lithium ion batteries at Higuera Street facility